Addressing Microbial Resistance Worldwide: Challenges over Controlling Life-Threatening Fungal Infections

Area of Science:

• Mycology
• Infectious Diseases
• Immunology

Background:

• Fungal infections are a significant global health concern, particularly in immunocompromised individuals.
• Emerging drug-resistant fungal pathogens, including Candida, Aspergillus, and Cryptococcus, present a growing clinical challenge.
• These fungi cause severe, systemic infections with high mortality rates and are implicated in coinfections, such as with COVID-19.

Purpose of the Study:

• To review the clinical relevance of drug resistance in significant fungal pathogens.
• To discuss the physiopathology of fungal infections and host-pathogen interactions.
• To highlight the need for coordinated scientific efforts to combat fungal infections and reduce mortality.

Main Methods:

• This study is a brief review of existing scientific literature.
• It synthesizes information on fungal drug resistance, clinical significance, and immunopathogenesis.
• The review focuses on key fungal genera: Candida, Aspergillus, and Cryptococcus.

Main Results:

• Drug resistance in fungi is a major bottleneck in treating infections.
• Fungal infections are associated with high mortality rates, especially systemic ones.
• The complex interplay between host immunity and fungal survival strategies influences infection outcomes.

Conclusions:

• Drug resistance phenotypes in clinically significant fungi require urgent attention.
• Further research into fungal immunopathogenesis is essential for developing effective treatments.
• A unified scientific approach is necessary to mitigate the spread and lethality of fungal diseases.